On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...